Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70.

Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004 Mar;39(3):764-9.

Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD).Hepatology. 2007 Mar;45(3):797-805.

Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.Liver Transpl. 2006;12(12 Suppl 3):S128.

Wiesner R, United Network for Organ Sharing Liver Disease Severity Score Committee, et al. Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology. 2003 Jan;124(1):91-6.

Dr. Patrick S. Kamath

MELD Na (UNOS/OPTN)

dialysis

creatinine

bilirubin

<p>Quantifies end-stage liver disease for transplant planning with sodium.</p>

Pranav Patel, MD

The MELD Score (Model For End-Stage Liver Disease) (12 and older) quantifies end-stage liver disease for transplant planning.

Creatinine

Bilirubin

Sodium

Combined MELD

UKELD Score

MELD Score (Original)

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function